Aims & Scope
Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents. Each issue contains a series of timely in-depth/mini-reviews and guest-edited issues written by leaders in the field covering a range of current topics in oncology and medicinal chemistry. The journal considers high-quality reviews and research papers for publication. Scientific areas within the scope of the journal include:
chemistry, prevention, diagnosis, and treatment of malignant diseases
● In silico studies of drug-target interaction in anti-cancer drug assessment
● Underlying biology and medicinal chemistry strategies for anti-cancer drug synthesis and development
● New drugs related to a specific target or target class for anticancer drugs
● Drug repositioning in cancer
● Clinical cancer research
● Radiotherapy and systemic treatment of cancer
● Other related areas
Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.
Anti-Cancer Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cancer drug discovery.
Differential Effects of Antofine N-Oxide on Solid Tumor and Leukemia Cells,
2014 :14 (10); 1315 - 1323
Tania Bour, Xianwen Yang, Weihong Li, Francois Bernardin, Tony Kaoma, Arnaud Muller, Laurent Vallar and Andre Steinmetz